FDA Approved: CLARITHROMYCIN — Supplemental Application (Sandoz Inc)

View source ↗

Summary

FDA approved a supplemental application for clarithromycin from Sandoz Inc, indicating continued/expanded approval for generic use of the drug.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Sinusitis
• Community-acquired Pneumonia
• Exacerbation of Chronic Bronchitis
• Helicobacter Pylori Infection
• Otitis Media
• Pharyngitis
• Skin and Skin Structure Infections
• Tonsillitis

Drugs mentioned

• clarithromycin (clarithromycin)

Snippet

SUPPL AP for CLARITHROMYCIN (CLARITHROMYCIN)